Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Surgical Pathology ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.Leukemia. 2022; 36: 1720-1748
- International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data.Blood. 2022; 140: 1200-1228
- Biologic and therapeutic implications of genomic alterations in acute lymphoblastic Leukemia.J Clin Med. 2021; 10: 3792
- Emerging molecular subtypes and therapeutic targets in B-cell precursor acute lymphoblastic leukemia.Front Med. 2021; 15: 347-371
- Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases.Proc Natl Acad Sci U S A. 2018; 115: E11711-E11720
- The application of RNA sequencing for the diagnosis and genomic classification of pediatric acute lymphoblastic leukemia.Blood Adv. 2020; 4: 930-942
- Whole-transcriptome analysis in acute lymphoblastic leukemia: a report from the DFCI ALL Consortium Protocol 16-001.Blood Adv. 2022; 6: 1329-1341
- Pediatric acute lymphoblastic leukemia, version 2.2020, NCCN clinical practice guidelines in oncology.J Natl Compr Canc Netw. 2020; 18: 81-112
- Monitoring minimal residual disease in acute leukemia: technical challenges and interpretive complexities.Blood Rev. 2017; 31: 63-75
- Strategies for minimal residual disease detection: current perspectives.Blood Lymphat Cancer. 2019; 9: 1-8
- A novel TCF3-HLF fusion transcript in acute lymphoblastic leukemia with a t(17;19)(q22;p13).Cancer Genet. 2012; 205: 669-672
- Hypercalcemia in childhood acute lymphoblastic leukemia: frequent implication of parathyroid hormone-related peptide and E2A-HLF from translocation 17;19.Leukemia. 2007; 21: 288-296
- Durable remissions in TCF3-HLF positive acute lymphoblastic leukemia with blinatumomab and stem cell transplantation.Haematologica. 2019; 104: e244-e247
- Genomics and drug profiling of fatal TCF3-HLF-positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options.Nat Genet. 2015; 47: 1020-1029
- Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia.Nat Commun. 2016; 7: 11790
- Clinical significance of novel subtypes of acute lymphoblastic leukemia in the context of minimal residual disease-directed therapy.Blood Cancer Discov. 2021; 2: 326-337
- Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia.N Engl J Med. 2014; 371: 1005-1015
- Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia.Cancer Cell. 2012; 22: 153-166
- Philadelphia chromosome-like acute lymphoblastic leukemia.Clin Lymphoma Myeloma Leuk. 2017; 17: 464-470
- Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia.Blood. 2010; 115: 5312-5321
- Increased Incidence of IKZF1 deletions and IGH-CRLF2 translocations in B-ALL of Hispanic/Latino children-a novel health disparity.Leukemia. 2021; 35: 2399-2402
- Targetable kinase gene fusions in high-risk B-ALL: a study from the Children's Oncology Group.Blood. 2017; 129: 3352-3361
- Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults.Blood. 2017; 129: 572-581
- How advanced are we in targeting novel subtypes of ALL?.Best Pract Res Clin Haematol. 2019; 32: 101095
- High frequency and poor outcome of philadelphia chromosome-like acute lymphoblastic leukemia in adults.J Clin Oncol. 2017; 35: 394-401
- The biology of B-Progenitor acute lymphoblastic leukemia.Cold Spring Harb Perspect Med. 2020; 10
- Genomic and outcome analyses of Ph-like ALL in NCI standard-risk patients: a report from the Children's Oncology Group.Blood. 2018; 132: 815-824
- New oncogenic subtypes in pediatric B-cell precursor acute lymphoblastic leukemia.Blood. 2017; 130: 1395-1401
- DUX hunting-clinical features and diagnostic challenges associated with DUX4-rearranged leukaemia.Cancers. 2020; 12
- Distinct clinical characteristics of DUX4- and PAX5-altered childhood B-lymphoblastic leukemia.Blood Adv. 2021; 5: 5226-5238
- Deregulation of DUX4 and ERG in acute lymphoblastic leukemia.Nat Genet. 2016; 48: 1481-1489
- Novel susceptibility variants at the ERG locus for childhood acute lymphoblastic leukemia in Hispanics.Blood. 2019; 133: 724-729
- CD371 cell surface expression: a unique feature of DUX4-rearranged acute lymphoblastic leukemia.Haematologica. 2019; 104: e352-e355
- DUX4r, ZNF384r and PAX5-P80R mutated B-cell precursor acute lymphoblastic leukemia frequently undergo monocytic switch.Haematologica. 2021; 106: 2066-2075
- Antigen expression patterns reflecting genotype of acute leukemias.Leukemia. 2002; 16: 1233-1258
- Sensitive and broadly applicable residual disease detection in acute myeloid leukemia using flow cytometry-based leukemic cell enrichment followed by mutational profiling.Am J Hematol. 2020; 95: 1148-1157
- DUX4r, ZNF384r and PAX5-P80R mutated B-cell precursor acute lymphoblastic leukemia frequently undergo monocytic switch.Haematologica. 2021; 106: 2066-2075
- N-terminus DUX4-immunohistochemistry is a reliable methodology for the diagnosis of DUX4-fused B-lymphoblastic leukemia/lymphoma (N-terminus DUX4 IHC for DUX4-fused B-ALL).Genes Chromosomes Cancer. 2022; 61: 449-458
- Molecular markers in ALL: clinical implications.Best Pract Res Clin Haematol. 2020; 33101193
- The genetic basis and cell of origin of mixed phenotype acute leukaemia.Nature. 2018; 562: 373-379
- Clinical characteristics and outcomes of B-ALL with ZNF384 rearrangements: a retrospective analysis by the Ponte di Legno Childhood ALL Working Group.Leukemia. 2021; 35: 3272-3277
- Genomic profiling of adult and pediatric B-cell acute lymphoblastic leukemia.EBioMedicine. 2016; 8: 173-183
- Transcriptome sequencing in pediatric acute lymphoblastic leukemia identifies fusion genes associated with distinct DNA methylation profiles.J Hematol Oncol. 2017; 10: 148
- Genomic landscape of pediatric B-other acute lymphoblastic leukemia in a consecutive European cohort.Haematologica. 2019; 104: 1396-1406
Moe Takeda MW, D Bhojwani, Z Gu, BL. Wood, G Raca, Alexandra E. Kovach. Distinct immunophenotypic features of noval genetic subtypes of pediatric B-lymphoblastic leukemia are recognizable in a clinical setting and can help direct molecular testing. Paper presented at: Society for Pediatric Pathology (SPP); March 19, 2022, 2022; Los Angeles, CA.
- Impact of immunophenotypic characteristics on genetic subgrouping in childhood acute lymphoblastic leukemia: Tokyo Children's Cancer Study Group (TCCSG) study L04-16.Genes Chromosomes Cancer. 2020; 59: 551-561
- Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia.Nat Commun. 2016; 7: 13331
- MEF2D fusions drive oncogenic Pre-BCR signaling in B-ALL.Blood Cancer Discov. 2020; 1: 18-20
Gordana Raca AEK, Z Hu, V Yellapantula, D Ostrow, A Doan, J Ji, R Schmidt, JA. Biegel, Z Gu, D Bhojwani. Transcriptome Sequencing (RNA-Seq) Allows Comprehensive Genomic Characterization of Pediatric B-Lymphoblastic Leukemia (B-ALL) in the Clinical Setting Paper presented at: Association for Molecular Pathology (AMP); November 3, 2022, 2022; Phoenix, AZ.
- PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia.Nat Genet. 2019; 51: 296-307
- PAX5 biallelic genomic alterations define a novel subgroup of B-cell precursor acute lymphoblastic leukemia.Leukemia. 2019; 33: 1895-1909
- PAX5 alterations in B-cell acute lymphoblastic leukemia.Front Oncol. 2022; 12: 1023606
- Intragenic amplification of PAX5: a novel subgroup in B-cell precursor acute lymphoblastic leukemia?.Blood Adv. 2017; 1: 1473-1477
- Characterization of PAX5 intragenic tandem multiplication in pediatric B-lymphoblastic leukemia by optical genome mapping.Blood Adv. 2022; 6: 3343-3346
- Wide diversity of PAX5 alterations in B-ALL: a Groupe Francophone de Cytogenetique Hematologique study.Blood. 2010; 115: 3089-3097
- PAX5 P80R mutation identifies a novel subtype of B-cell precursor acute lymphoblastic leukemia with favorable outcome.Blood. 2019; 133: 280-284
- Favorable outcome of NUTM1-rearranged infant and pediatric B cell precursor acute lymphoblastic leukemia in a collaborative international study.Leukemia. 2021; 35: 2978-2982
- NUTM1 is a recurrent fusion gene partner in B-cell precursor acute lymphoblastic leukemia associated with increased expression of genes on chromosome band 10p12.31-12.2.Haematologica. 2019; 104: e455-e459
- Cryptic recurrent ACIN1-NUTM1 fusions in non-KMT2A-rearranged infant acute lymphoblastic leukemia.Genes Chromosomes Cancer. 2020; 59: 125-130
Gagnon MF, Sill D, Meyer R, et al. Frequency of double-hit cytogenetics and MYC rearrangement partners in pediatric (<18) and yound adult (18-30) patients: a 10-year Mayo Clinic review. Paper presented at: 21st European Association of Haematopathology (EAHP) Congress; September 20, 2022, 2022; Florence, Italy.
- Novel three-break rearrangement and cryptic translocations leading to colocalization of MYC and IGH signals in B-cell acute lymphoblastic leukemia.Cancer Genet Cytogenet. 2006; 165: 180-184
- t(8;14)(q11;q32) in acute lymphoid leukemia: description of two cases.Cancer Genet Cytogenet. 1993; 67: 55-58
- Immunophenotypic and cytogenetic findings of B-lymphoblastic leukemia/lymphoma associated with combined IGH/BCL2 and MYC rearrangement.Cytometry B Clin Cytom. 2017; 92: 310-314
- De novo acute lymphoblastic leukemia-like disease of high grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements: a case report and literature review.BMC Clin Pathol. 2017; 17: 21
- IG-MYC (+) neoplasms with precursor B-cell phenotype are molecularly distinct from Burkitt lymphomas.Blood. 2018; 132: 2280-2285
- Erroneous class switching and false VDJ recombination: molecular dissection of t(8;14)/MYC-IGH translocations in Burkitt-type lymphoblastic leukemia/B-cell lymphoma.Mol Oncol. 2013; 7: 850-858
- B Lymphoblastic Leukemia/Lymphoma With Burkitt-like Morphology and IGH/MYC Rearrangement: Report of 3 Cases in Adult Patients.Am J Surg Pathol. 2018; 42: 269-276
- Molecular characteristics of terminal deoxynucleotidyl transferase negative precursor B-cell phenotype Burkitt leukemia with IGH-MYC rearrangement.Genes Chromosomes Cancer. 2020; 59: 255-260
- B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.Am J Surg Pathol. 2010; 34: 327-340
- Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocations.Haematologica. 2009; 94: 935-943
- Concurrent translocation of BCL2 and MYC with a single immunoglobulin locus in high-grade B-cell lymphomas.Leukemia. 2005; 19: 659-663
- Mutational landscape of TdT+ large B-cell lymphomas supports their distinction from B-lymphoblastic neoplasms: a multiparameter study of a rare and aggressive entity.Am J Surg Pathol. 2022; 46: 71-82
- Genomic profile of TdT(positive) MYC/BCL2 rearranged high-grade B-cell lymphoma supporting its diagnosis as mature aggressive lymphoma.Cytometry B Clin Cytom. 2022; 102: 448-450
- Blastoid high-grade B-cell lymphoma initially presenting in bone marrow: a diagnostic challenge.Mod Pathol. 2022; 35: 419-426
- High-grade B-cell lymphomas with TdT expression: a diagnostic and classification dilemma.Mod Pathol. 2019; 32: 48-58
- Double- and triple-hit lymphomas can present with features suggestive of immaturity, including TdT expression, and create diagnostic challenges.Leuk Lymphoma. 2016; 57: 2626-2635
- Immunophenotyping of mature B-cell lymphomas.in: Porwit A.B.M. Multiparameter flow cytometry in the diagnosis of hematologic malignancies. Cambridge University Press, Cambridge, UK2018: 105-127
- Diffuse large B-cell lymphoma in pediatric patients belongs predominantly to the germinal-center type B-cell lymphomas: a clinicopathologic analysis of cases included in the German BFM (Berlin-Frankfurt-Munster) Multicenter Trial.Blood. 2006; 107: 4047-4052
- Pediatric aggressive mature B-Cell lymphomas, version 3.2022, NCCN clinical practice guidelines in oncology.J Natl Compr Canc Netw. 2022; 20: 1267-1275
- Non-Hodgkin lymphoma in children and adolescents: progress through effective collaboration, current knowledge, and challenges ahead.J Clin Oncol. 2015; 33: 2963-2974
- Non-Hodgkin lymphoma across the pediatric and adolescent and young adult age spectrum.Hematology Am Soc Hematol Educ Program. 2016; 2016: 589-597
- Pediatric Aggressive Mature B-Cell Lymphomas. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines).2022 (Available at:) (Accessed October 13, 2022)
- Intussusception in children: lessons learned from intestinal lymphoma as a rare lead-point.Pediatr Surg Int. 2019; 35: 879-885
- Primary pediatric non-hodgkin lymphomas of the gastrointestinal tract: a population-based analysis.Anticancer Res. 2019; 39: 6413-6416
- Mature B-NHL in children, adolescents and young adults: current therapeutic approach and emerging treatment strategies.Br J Haematol. 2019; 185: 1071-1085
- Revised international pediatric non-hodgkin lymphoma staging system.J Clin Oncol. 2015; 33: 2112-2118
- Classification, staging and end results of treatment of childhood non-Hodgkin's lymphomas: dissimilarities from lymphomas in adults.Semin Oncol. 1980; 7: 332-339
- The role of surgery in abdominal Burkitt's lymphoma.J Pediatr Surg. 1992; 27: 236-240
- Clinical implications and surgical management of intussusception in pediatric patients with Burkitt lymphoma.J Pediatr Surg. 2007; 42 ([discussion: 1001]): 998-1001
- Burkitt's lymphoma: clinicopathologic features and differential diagnosis.Oncol. 2006; 11: 375-383
- Molecular biology of Burkitt's lymphoma.J Clin Oncol. 2000; 18: 3707-3721
- A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling.N Engl J Med. 2006; 354: 2419-2430
- The clinicopathologic spectrum of mature aggressive B cell lymphomas.Virchows Arch. 2017; 471: 453-466
- The 11q-Gain/Loss Aberration Occurs Recurrently in MYC-Negative Burkitt-like Lymphoma With 11q Aberration, as Well as MYC-Positive Burkitt Lymphoma and MYC-Positive High-Grade B-Cell Lymphoma, NOS.Am J Clin Pathol. 2017; 149: 17-28
- Experience with provisional WHO-entities large B-cell lymphoma with IRF4-rearrangement and Burkitt-like lymphoma with 11q aberration in paediatric patients of the NHL-BFM group.Br J Haematol. 2020; 190: 753-763
- Update on pediatric and young adult mature lymphomas.Clin Lab Med. 2021; 41: 359-387
- Burkitt-like lymphoma with 11q aberration: a germinal center-derived lymphoma genetically unrelated to Burkitt lymphoma.Haematologica. 2019; 104: 1822-1829
- Minimal treatment of low-risk, pediatric lymphocyte-predominant hodgkin lymphoma: a report from the children's oncology group.J Clin Oncol. 2016; 34: 2372-2379
- Nodular lymphocyte predominant Hodgkin lymphoma: experience of polish pediatric leukemia/lymphoma study group.Pediatr Hematol Oncol. 2021; 38: 609-619
- When is surgical resection alone appropriate treatment for pediatric nodular lymphocyte-predominant Hodgkin lymphoma?.SAGE open medical case reports. 2021; 9 (2050313x211022422)
- The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee.Blood. 2022; 140: 1229-1253
- Nodular lymphocyte predominant Hodgkin lymphoma: pathology, clinical course and relation to T-cell/histiocyte rich large B-cell lymphoma.Pathology. 2020; 52: 142-153
- Characterization of variant patterns of nodular lymphocyte predominant hodgkin lymphoma with immunohistologic and clinical correlation.Am J Surg Pathol. 2003; 27: 1346-1356
Panayi C, Akarca A, Vitale L, et al. Deciphering the microenvironment of NLPHL by multispectral immunofluorescence and digital image analysis generates biomarkers relevant to diagnostic and prognostic stratification. 21st European Association of Haematopathology (EAHP) Congress; September 19, 2022, 2022; Florence, Italy.
- Follicular lymphomas in children and young adults: a comparison of the pediatric variant with usual follicular lymphoma.Am J Surg Pathol. 2013; 37: 333-343
- Pediatric-type nodal follicular lymphoma: a biologically distinct lymphoma with frequent MAPK pathway mutations.Blood. 2016; 128: 1093-1100
- Primary follicular lymphoma of the testis in childhood: an entity with peculiar clinical and molecular characteristics.J Clin Pathol. 2002; 55: 684-688
- Primary follicular lymphoma of the testis in childhood.Cancer. 1999; 85: 1626-1635
- Follicular large cell lymphoma localized to the testis in children.J Urol. 2002; 168: 225-228
- Primary follicular lymphoma of the testis in children and adolescents.J Pediatr Hematol Oncol. 2012; 34: 68-71
- OncoKids: a comprehensive next-generation sequencing panel for pediatric malignancies.J Mol Diagn. 2018; 20: 765-776
- EZH2 mutations are frequent and represent an early event in follicular lymphoma.Blood. 2013; 122: 3165-3168
- Primary follicular lymphoma of the testis: excellent outcome following surgical resection without adjuvant chemotherapy.J Pediatr Hematol Oncol. 2004; 26: 104-107
- A unifying hypothesis for PNMZL and PTFL: morphological variants with a common molecular profile.Blood Adv. 2022; 6: 4661-4674
- Pediatric-Type Indolent B-Cell Lymphomas With Overlapping Clinical, Pathologic, and Genetic Features.Am J Surg Pathol. 2022; 46: 1397-1406
Jaffe ES. Pediatric nodal marginal zone lymphoma (PNMZL) shares a common molecular profile with pediatric-type follicular lymphoma (PTFL). European Association of Hematopathology (EAHP); September 20, 2022, 2022; Florence, Italy.
- Large B-cell lymphoma with IRF4 rearrangement.in: Swerdlow S.H. Campo E. Harris N.L. WHO classification of tumours of haematopoietic and lymphoid tissues. Revised. 4th ed. International Agency for Research on Cancer, Lyon2017: 280-281
- Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults.Blood. 2011; 118: 139-147
Wang D, Ahn J. Ileocoloc intussusception and atypical FISH signal pattern in a pediatric patient with large B-cell lymphoma with IRF4 rearrangement. 21st European Association of Haematopathology (EAHP) Congress; September 21, 2022, 2022; Florence, Italy.
- IRF4 translocation status in pediatric follicular and diffuse large B-cell lymphoma patients enrolled in Children's Oncology Group trials.Pediatr Blood Cancer. 2019; 66: e27770
Article info
Publication history
Published online: March 08, 2023
Publication stage
In Press Corrected ProofIdentification
Copyright
© 2023 Elsevier Inc. All rights reserved.
